5-fluorodopamine has been researched along with Disease Exacerbation in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arbizu, J; Blesa, J; Cavada, C; Collantes, M; García-García, D; Iglesias, E; Juri, C; Martí-Climent, J; Obeso, JA; Peñuelas, I; Prieto, E; Richter, JA; Rodríguez-Oroz, MC; Zubieta, JL | 1 |
Goldstein, DS; Holmes, C; Park, MY; Sewell, L; Sharabi, Y | 1 |
Arola, J; Asa, SL; Sane, T; Schalin-Jäntti, C | 1 |
Dendi, R; Goldstein, DS; Holmes, C; Li, ST | 1 |
4 other study(ies) available for 5-fluorodopamine and Disease Exacerbation
Article | Year |
---|---|
Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
Topics: Animals; Brain Mapping; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Dyskinesias; Female; Macaca fascicularis; Male; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Severity of Illness Index; Signal Processing, Computer-Assisted; Tetrabenazine | 2010 |
Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.
Topics: Aged; alpha-Synuclein; Autonomic Denervation; Dementia; Dihydroxyphenylalanine; Disease Progression; Dopamine; Dopaminergic Neurons; Gait Disorders, Neurologic; Hallucinations; Humans; Lewy Body Disease; Male; Neostriatum; Norepinephrine; Parkinson Disease; Radiopharmaceuticals; Shy-Drager Syndrome; Sympathetic Nervous System | 2012 |
Recurrent acute-onset Cushing's syndrome 6 years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Corticotropin-Releasing Hormone; Cushing Syndrome; Disease Progression; Dopamine; Humans; Hydrocortisone; Ki-67 Antigen; Male; Neuroendocrine Tumors; Radiopharmaceuticals; Thymus Neoplasms | 2013 |
Progressive loss of cardiac sympathetic innervation in Parkinson's disease.
Topics: Disease Progression; Dopamine; Fluorine Radioisotopes; Heart Conduction System; Humans; Hypotension, Orthostatic; Middle Aged; Parkinson Disease; Sympathetic Nervous System; Tomography, Emission-Computed | 2002 |